awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39394704-D7EA8320-29BE-428E-B28F-BF2A60F4D598
Q39394704-D7EA8320-29BE-428E-B28F-BF2A60F4D598
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39394704-D7EA8320-29BE-428E-B28F-BF2A60F4D598
Examination of noninferiority, safety, and tolerability of lopinavir/ritonavir and raltegravir compared with lopinavir/ritonavir and tenofovir/ emtricitabine in antiretroviral-naïve subjects: the progress study, 48-week results.
P2860
Q39394704-D7EA8320-29BE-428E-B28F-BF2A60F4D598
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39394704-D7EA8320-29BE-428E-B28F-BF2A60F4D598
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9e7a6818da561235e6daeec4eac4cf567df2bf7c
P2860
Class-sparing regimens for initial treatment of HIV-1 infection.